0
RSS Email Alerts
Please Wait... Processing your request... Please Wait.

Evidence-Based Dermatology: Study |  October 01, 2010 FREE
Pemphigus and Osteoporosis:  A Case-Control Study
Yonit Wohl, MD, MHA; Jacob Dreiher, MD, MPH; Arnon D. Cohen, MD, MPH, PhD
Arch Dermatol. 2010;146(10):1126-1131. doi:10.1001/archdermatol.2010.257.
Practice Gaps |  October 01, 2010
Underutilization of Prophylaxis for Osteoporosis:  Comment on “Pemphigus and Osteoporosis”
Erik J. Stratman, MD
Arch Dermatol. 2010;146(10):1131. doi:10.1001/archdermatol.2010.250.
Editorial |  May 01, 2010
Fracturing Support for the Role of Systemic Retinoid Therapy as a Cause of Bone Demineralization
John J. DiGiovanna, MD
Arch Dermatol. 2010;146(5):551-553. doi:10.1001/archdermatol.2010.81.
Correspondence |  November 01, 2002
Is Retinoid-Induced Osteopenia Reversible?
Aaron M. Milstone, MD; Leonard M. Milstone, MD
Arch Dermatol. 2002;138(11):1516. doi:10.1001/archderm.138.11.1515.
Review |  April 01, 2001 FREE
Suggested Rationale for Prevention and Treatment of Glucocorticoid-Induced Bone Loss in Dermatologic Patients
Gil Yosipovitch, MD; Tan Suat Hoon, MD; Goh Chee Leok, MD
Arch Dermatol. 2001;137(4):477-481. doi:10-1001/pubs.Arch Dermatol.-ISSN-0003-987x-137-4-dre0005.
Correspondence |  March 01, 2000
Isotretinoin Has Yet to Be Shown to Affect Bone Density
S. Elizabeth Whitmore, MD
Arch Dermatol. 2000;136(3):424. doi:.
Observation |  August 01, 1999 FREE
Bone Densities in Patients Receiving Isotretinoin for Cystic Acne
Sancy A. Leachman, MD, PhD; Karl L. Insogna, MD; Lee Katz, MD; et al.
Arch Dermatol. 1999;135(8):961-965. doi:10.1001/archderm.135.8.961.

Sign In

Register for a FREE personal account

and access these and other features:

Register Now

Want to Subscribe?

Learn More about subscription options.

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

From The JAMA Network
JAMA Internal Medicine
Viewpoint  |  May 27, 2013
Overuse of Health Care Services:  When Less Is More . . . More or Less
Allison Lipitz-Snyderman, PhD; Peter B. Bach, MD, MAPP
JAMA Internal Medicine
Invited Commentary  |  February 4, 2013
Are Calcium Supplements Harmful to Cardiovascular Disease?:  Comment on “ Dietary and Supplemental Calcium Intake and Cardiovascular Diseases Mortality: The National Institutes of Health–AARP Diet and Health Study”
Susanna C. Larsson, PhD
JAMA Ophthalmology
Small Case Series  |  Feb 2013
Squamous Metaplasia of the Conjunctiva:  A Previously Unrecognized Adverse Effect of Risedronate Sodium
Ivayla I. Geneva, BA; Ralph C. Eagle, MD; Ann Barker-Griffith, MD, FRCSC; et al.
JAMA Internal Medicine
Editor's Correspondence  |  Jan 14, 2013
Are Bisphosphonates Associated With an Increased Risk of Atypical Femoral Fractures as a Class?
Michael Pazianas, MD
© 2013 American Medical Association. All Rights Reserved.
Powered bySilverchair Information Systems